loader image

About FDA

As a regulatory agency under the Department of Health, the Food and Drug Administration, created under Republic Act No. 3720, series of 1963, as amended by Executive Order 175, series of 1987, otherwise known as the “Food, Drugs and Devices, and Cosmetics Act”, and subsequently Republic Act No. 9711 otherwise known as “The Food and Drug Administration Act of 2009”, is mandated to ensure the safety, efficacy or quality of health products which include food, drugs, cosmetics, devices, biologicals, vaccines, in-vitro diagnostic reagents, radiation-emitting devices or equipment, and household/urban hazardous substances, including pesticides and toys, or consumer products that may have an effect on health which require regulations as determined by the FDA.

Among others, the FDA is also mandated to enforce the provisions of the following laws:

  • RA 9502, or The Universally Accessible Cheaper and Quality Medicine Act of 2008
  • RA 6675, or The Generics Act Of 1988,
  • RA 10918, or The Pharmacy Law,
  • RA 9211, or The Tobacco Regulation Act of 2003
  • RA 7394, or The Consumer Act of the Philippines
  • RA 7581/10623, or The Price Act
  • RA 10611, or The Food Safety Act of 2013
  • RA  8172, or The ASIN Law,
  • RA 8203, or The Special Law on Counterfeit Drug
  • RA 8976, or The Food Fortification Law
  • RA 9165, or The Comprehensive Dangerous Drugs Act
  • RA 9257, or The Expanded Senior Citizens Act of 2003
  • PD No. 881, or The Household Hazardous Act
  • EO No. 51, or The Milk Code of the Philippines
  • RA 10354, or The Responsible Parenthood and Reproductive Health Bill of 2012
  • PD 856, or The Code of Sanitation of the Philippines

To guarantee the safety, quality, purity, efficacy of products in order to protect and promote the right to health of the general public.

The Food and Drug Administration to be an internationally recognized center of excellence in health product regulation by 2026.

In order to protect and promote the right to health of the Filipino people and to establish and maintain an effective health products regulatory system responsive to the country’s health needs and problems, the FDA shall perform the following functions as provided by existing laws:
  • To establish safety or efficacy standards and quality measures for foods, drugs and devices and cosmetics and other health product;
  • To undertake appropriate health manpower development and research, responsive to the country’s health needs and problems;
  • To assume primary jurisdiction in the collection of samples of health products;
  • To analyze and inspect health products;
  • To establish analytical data to serve as basis for the preparation of health products standards, and to recommend standards of identity, purity, safety, efficacy, quality and fill of container;
  • To issue certificates of compliance with technical requirements to serve as basis for the issuance of appropriate authorization and spot-check for compliance with regulations regarding operation of manufacturers, importers, exporters, distributors, wholesalers, drug outlets, and other establishments and facilities of health products, as determined by the FDA;
  • To conduct appropriate tests on all applicable health products prior to the issuance of appropriate authorizations to ensure safety, efficacy, purity, and quality;
  • To require all manufacturers, traders, distributors, importers, exporters, wholesalers, retailers, consumers, and non-consumer users of health products to report to the FDA any incident that reasonably indicates that said product has caused or contributed to the death, serious illness or serious injury to a consumer, a patient, or any person;
  • To issue cease and desist orders motu propio or upon verified complaint for health produts, whether or not registered with the FDA Provided, That for registered health products, the cease and desist order is valid for thirty (30) days and may be extended for sixty (60) days only after due process has been observed;
  • To order the ban, recall, and/or withdrawal of any health product, after due process, found to have caused the death, serious illness or serious injury to a consumer or patient, or is found to be imminently injurious, unsafe, dangerous, or grossly deceptive, and to require all concerned to implement the risk management plan which is a requirement for the issuance of the appropriate authorization;
  • To strengthen the post market surveillance system in monitoring health products as defined in this Act and incidents of adverse events involving such products;
  • To develop and issue standards and appropriate authorizations that would cover establishments, facilities and health products;
  • To conduct, supervise, monitor and audit research studies on health and safety issues of health products undertaken by entities duly approved by the FDA;
  • To prescribe standards, guidelines, and regulations with respect to information, advertisements and other marketing instruments and promotion, sponsorship, and other marketing activities about the health products;
  • To maintain bonded warehouses and/or establish the same, whenever necessary or appropriate, as determined by the director-general for confiscated goods in strategic areas of the country especially at major ports of entry; and
  • To exercise such other powers and perform such other functions as may be necessary to carry out its duties and responsibilities.
  • To protect and promote the right to health of the Filipino people by ensuring the safety, efficacy, quality, and purity of foods, drugs, devices, and cosmetics, and
  • To establish and maintain an effective health products regulatory system responsive to the country’s health needs and problems.
Ensure the safety, efficacy, quality and purity of health products by fostering integrity, transparency and excellence; developing and maintaining evidence-based standards and policies, in a healthy and safe work environment.
Bawat Kawani ng FDA, Lingkod Bayani"
EXCELLENCE - Pagiging Mahusay refers to our Highest degree of professionalism and superior work standard in discharging one's duty
LEADERSHIP - Mahusay na Pamumuno refers to the management thinking that all employees in all levels of public service who, at their best, care and do something about the challenges faced by the FDA
INTEGRITY -  Pagiging Matapat refers to our consistent adherence to strong and ethical principles, wether alone or in public
PATRIOTISM - Pagiging Makabayan refers to our love for our country and fellowmen
SPIRITUALITY - Pagiging Maka-Diyos refers to our belief, love and faith for a Higher Being
Dr. Oscar G. Gutierrez, Jr., MPA Officer-In-Charge-Director General  Office of the Director General
Atty. Ronald R. De Veyra, MBA, CESO II Deputy Director General for Internal Management  Office of the Deputy Director General for Internal Management
Arnold G. Alindada, Dr. HCM, MPH, RMT Director II Officer-In-Charge Deputy Director General for Field Regulatory Operations Office  Office of the Deputy Director General for Field Regulatory Operations Office
Engr. Ana Trinidad F. Rivera Director IV  Center for Cosmetics and Household Urban Hazardous Substances Regulation and Research
Jesusa Joyce N. Cirunay Director IV  Center for Drug Regulation and Research
Engr. Ma. Cecilia C. Matienzo Director IV  Center for Device Regulation, Radiation and Health Research
Pilar Marilyn M. Pagayunan Director IV  Center for Food Regulation and Research
Jocelyn E. Balderrama, RPh., MBA Director III  Common Services Laboratory
Atty. Emilio L. Polig, Jr. Director III  Legal Services Support Center
 Estrellita B. Pastolero, MGM Officer-In-Charge  Food and Drug Action Center
Irene Florentino-Fariñas, RPh., MD, MNSA Director II, Officer-In-Charge  Policy and Planning Service
 Gomel C. Gabuna, LlB, MDM, CESE Director II  North Luzon Cluster, Field Regulatory Operations Officer
 Carolyn P. Custodio Director II, Officer-In-Charge  South Luzon Cluster, Field Regulatory Operations Office
 Rica Reina C. Aumentado Director II, Officer-In-Charge  Visayas Cluster, Field Regulatory Operations Office
Deborah S. Legaspi Director II  Mindanao East Cluster, Field Regulatory Operations Office
Annette B. Tan Director II  Mindanao West Cluster, Field Regulatory Operations Office
  Nadia D. Navarro, FDRO II
  Rochelle T. Bayanes, FDRO II
  Giovanni G. Monang, FDRO II



Veronica F. Obille, FDRO III/Regional Supervisor

  Airene Z. Barlin, FDRO II
  Jeffrey J. Gamboa, FDRO II
  Imelda B. Calmada, FDRO II


Janelle L. Lim, FDRO II

Alegria G. Ong, FDRO III & RFO II Supervisor

  Janelle L. Lim, FDRO II
  Shanida Joy O. Singson, FDRO II
  Consuelo R. Ricablanca, FDRO II
  Dianne Cristelle S. Maningas, FDRO II
  Krisha Melody G. Lavadia, FDRO II
  Rose Agatha D. Pagalilauan, LO III


Clarissa A. Mendoza, FDRO III - Drug

Virginia P. Timbol, FDRO IV & RFO III Supervisor

  Alona O. Palmares, FDRO III
  Clarissa A. Mendoza, FDRO III
  Gia Heida N. Bognot, FDRO II
  Ma. Concepcion P. Canilao, FDRO II
  Benedict R. Balajadia, FDRO II
  Imee S. Patriarca, FDRO II
  Ronald D. Tiglao, FDRO II
  Kristie Ann T. Abuel, FDRO II
  Diana Mae C. Castro, FDRO I
  Krinessa S. Manlapat, FDRO II


Ma. Lynn Rachelle A. Natividad, FDRO III Fleurdelis E. Mendiola, Pharmacist IV
Rioriza A. Ortilano, FDRO III Archie M. Balilo, FDRO II
Ma. Lolita B. Abo-ol, FDRO III Gian Angelo L. Cruz, FDRO II
Marissa C. Fajardo, FDRO III Theresa A. Dizon, FDRO II
Don Bryan A. Orendain, FDRO III Cristal Jule B. Dolendo, FDRO II
Ma. Suzette R. Sta. Clara, FDRO III Maureen D. Mabulay, FDRO II
Angeli B. Casala, FDRO II Gladys Jane M. Martinez, FDRO II
Frances Glorie D. De Luna, FDRO II Mark Anthony A. Polpol, FDRO II
Mary Angeline V. Francisco, FDRO II Sarah Y. Manucdoc, FDRO I
Michael E. Galang, FDRO II Clare Louise Reyes, FDRO I
Lelian B. Indac, FDRO II  
Jackerwin R. Maur, FDRO II  
Cristy Hanna V. Mendoza, FDRO II  
Rowena K. Velasco, FDRO II  
Irene A. Dimayacyac, FDRO II  


  Cristian V. Martinez, FDRO II
  Richard P. Gerinas, FDRO II


  Luzvimin G. Atienza, FDRO III
  Lilibeth D. Mayor, FDRO II
  Ephraim Joseph D. Dela Cruz, FDRO II


Edwin E. Castillo, Jr., FDRO II Emily M. Espinas, FDRO III
  Silvia C. Lopez, FDRO II
  Ma. Dolores V. Alegre, FDRO II
  Edwin E. Castillo, Jr., FDRO II
  Elias J. Almajeda, FDRO II
  Ma. Jehan A. Icamen, FDRO II
  Rica D. Morales, FDRO II
  Rachelle Flor Faustino-Agsolid, FDRO II
  Hazel Ann A. Alagaban, FDRO I


  Mary Jade S. Tan, FDRO II
  Ma. Gina G. Joquico, FDRO II
  Maricon G. Dimatulac, FDRO II
  Mabel U. Concepcion, FDRO II
  Gladys Mae V. Sanchez, FDRO II
  Arlene G. Punsalan, FDRO II
  Gemma T. Tabiano, FDRO II


Ma. Salome R. Largo, FDRO II Sarah C. Oriol, FDRO III
Irish B. Samar, FDRO I Therese Antoniette V. Cuyos, FDRO II
  Ma. Salome R. Largo, FDRO II
  Christa Marie L. Baritua, FDRO II
  Lucrecia O. Matugas, FDRO II
  Vicky R. Sibala, FDRO II
  Diana A. Tindoy, FDRO I
  Krissa Joy E. Elardo, FDRO I
  Irish B. Samar, FDRO I


Benczint Benedikt C. Ortega, FDRO III Benczint Benedikt C. Ortega, FDRO III
  Ma. Christine T. Ty, FDRO II
  Pinky A. Bantanos, FDRO II
  Khin Janique M. Lagonoy, FDRO I
  Laura Marie C. Carcueva, FDRO II
  Sheryl Mae C. Gente, FDRO II
  Emelyn O. Mercado, FDRO II
  Ma. Cielo R. Yee, FDRO II


  Kathrina U. Hassan, FDRO III
  Gladys Valerie Kaye R. Angeles, FDRO II


RFO 10
Lorelie Joy A. Acha, FDRO II Lorelie Joy A. Acha, FDRO II
  Anthonette K. Melgo, FDRO II
  Desie A. Maghamil, FDRO II
  Ma. Auralynn V. Macalisang, FDRO II


RFO 11
Eba Marie Antonette W. Inis, FDRO IV & RFO XI Regional Supervisor Phyllis Irene Pineda – FDRO III
  Araceli V. Arceo, FDRO II


RFO 12
  Nicanora D. Rabara, FDRO III & RFO XII Regional Supervisor
Mayen P. Abdullah, FDRO II Mayen P. Abdullah, FDRO II
  John David O. Garduque, FDRO II
  Maria Celestina B. Pascual, FDRO II
  Jeselle L. Mationg, FDRO II


RFO 13
  Perla B. Alvizo, FDRO III/ Regional Supevisor
Keith Bryan Vincent R. Angeles, FDRO II Keith Bryan Vincent R. Angeles, FDRO II
Lucille Glenda T. Bug-os, FDRO II Lucille Glenda T. Bug-os, FDRO II
  Virginia K. Delani, FDRO II
  Richel B. Prado, FDRO II
  Potenciana A. Santiago, FDRO II